Drugs / Protollin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT07187141 Comparator | Nov 2021 → Sep 2022 | Alzheimer disease | Brigham and Women's Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Protollin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07187141 ↗ |
| Route | Intranasal | “will be administered in two, 0.1 μL sprays, one per nostril.” NCT07187141 ↗ |